METHOD FOR MONITORING OR PREDICTING WHETHER A PATIENT SUFFERING FROM OBESITY IS RESPONDING OR WILL RESPOND TO A VERY-LOW-CALORIE KETOGENIC DIET (VLCKD)

Patent number:

EP4092137A1

No items found.

The present invention refers to an in vitro method for screening and/or selecting genes whose methylation status indicates whether a patient suffering from obesity is responding or will respond to a treatment with VLCKD. Moreover, the present invention refers to an in vitro method for monitoring or predicting whether a patient suffering from obesity is responding or will respond to VLCKD.

Countries:

Spain

Regions:

Galicia

Castille and Leon

Centers:

INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA, UNIVERSIDAD DE SANTIAGO DE COMPOSTELA, SERGAS, UNIVERSIDAD DE VALLADOLID

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

The present invention refers to a method for monitoring or predicting whether a patient suffering from obesity is responding or will respond to VLCKD, particularly for monitoring or predicting whether an improvement of metabolic parameters has occurred in a patient suffering from obesity after the induction of nutritional ketosis by means of a treatment with VLCKD.

Comments

Other related patents

Health

PROTEIN TYROSINE PHOSPHATASES AS BIOMARKERS FOR HEPATOCELLULAR CARCINOMA AND USES THEREOF

Countries

Belgium

Health

DUAL DEVICE FOR HANDING BIOLOGICAL MATERIAL IN LABORATORIES

Countries

Spain

Health

Non–invasive method for the objective assessment of the intraocular scattering of the cornea and the crystaline lens

Countries

Spain

Get back to patents directory